| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | EOMES NCOA2 FOXO1 TTC8 SP1 MDFIC ARNT PTPRN ARID2 PPP1R13B NCOA1 VGLL4 BSN USF1 EP300 | 3.66e-07 | 753 | 82 | 15 | GO:0008134 |
| GeneOntologyMolecularFunction | chromatin binding | EOMES NCOA2 FOXO1 PHC3 POLG ATAD2B NCOA1 POU2F1 ZNF683 CHD8 KDM6A EP300 PHC1 NCOA5 | 1.71e-06 | 739 | 82 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.79e-04 | 140 | 82 | 5 | GO:0001221 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 3.13e-04 | 417 | 82 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 4.69e-04 | 37 | 82 | 3 | GO:0043425 | |
| GeneOntologyMolecularFunction | aryl hydrocarbon receptor binding | 5.89e-04 | 9 | 82 | 2 | GO:0017162 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 5.89e-04 | 9 | 82 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 5.89e-04 | 9 | 82 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 6.31e-04 | 582 | 82 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.42e-03 | 54 | 82 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.47e-03 | 14 | 82 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.55e-03 | 303 | 82 | 6 | GO:0003713 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 1.35e-05 | 271 | 83 | 8 | GO:0032869 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | EOMES SP1 SPRY2 IFT140 DLC1 FN1 ENAH NCOA1 POU2F1 GREM1 MYO15A KDM6A | 2.71e-05 | 713 | 83 | 12 | GO:0048598 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | EOMES NCOA2 FOXO1 SP1 KMT2C CXCR3 ARNT PTPRN ARID2 NCOA1 POU2F1 CHD8 MAML2 GREM1 USF1 KDM6A EP300 | 3.20e-05 | 1390 | 83 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | heart development | EOMES PRICKLE4 IFT140 MAP2K4 DLC1 FN1 ARID2 VGLL4 GREM1 KDM6A EP300 GAA | 4.86e-05 | 757 | 83 | 12 | GO:0007507 |
| GeneOntologyBiologicalProcess | embryo development | EOMES SP1 SPRY2 IFT140 ARNT DLC1 FN1 ARID2 ENAH NCOA1 POU2F1 CHD8 GREM1 MYO15A USPL1 KDM6A EP300 | 4.87e-05 | 1437 | 83 | 17 | GO:0009790 |
| GeneOntologyBiologicalProcess | circulatory system development | EOMES FOXO1 SP1 PRICKLE4 SPRY2 IFT140 MAP2K4 CXCR3 DLC1 FN1 ARID2 CEACAM6 VGLL4 GREM1 KDM6A EP300 GAA | 5.08e-05 | 1442 | 83 | 17 | GO:0072359 |
| GeneOntologyBiologicalProcess | glucose metabolic process | 5.75e-05 | 244 | 83 | 7 | GO:0006006 | |
| GeneOntologyBiologicalProcess | response to insulin | 7.04e-05 | 342 | 83 | 8 | GO:0032868 | |
| GeneOntologyBiologicalProcess | viral transcription | 8.77e-05 | 58 | 83 | 4 | GO:0019083 | |
| GeneOntologyBiologicalProcess | cellular response to nutrient levels | 8.99e-05 | 262 | 83 | 7 | GO:0031669 | |
| GeneOntologyBiologicalProcess | positive regulation of female receptivity | 9.55e-05 | 4 | 83 | 2 | GO:0045925 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 9.55e-05 | 4 | 83 | 2 | GO:1904017 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | TTC8 SP1 SPRY2 IFT140 DLC1 POC1A ARID2 CEACAM8 CEACAM6 POU2F1 GREM1 MYO15A KDM6A EP300 GAA | 1.47e-04 | 1269 | 83 | 15 | GO:0009887 |
| GeneOntologyBiologicalProcess | hexose metabolic process | 1.48e-04 | 284 | 83 | 7 | GO:0019318 | |
| GeneOntologyBiologicalProcess | cellular response to peptide hormone stimulus | 1.49e-04 | 381 | 83 | 8 | GO:0071375 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | NCOA2 FOXO1 CACNA1A CACNA1E SP1 MAP2K4 PTPRN CEACAM8 NCOA1 CEACAM6 ZNF683 USF1 KDM6A EP300 PHC1 NCOA5 | 1.89e-04 | 1450 | 83 | 16 | GO:1901701 |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | NCOA2 FOXO1 CACNA1A SP1 CEACAM8 NCOA1 CEACAM6 DDI1 USF1 EP300 NCOA5 | 2.08e-04 | 752 | 83 | 11 | GO:1901699 |
| GeneOntologyBiologicalProcess | behavior | NCOA2 CACNA1A CACNA1E KLHL1 CEACAM8 NCOA1 CEACAM6 CHD8 REG1B MYO15A EP300 GAA | 2.25e-04 | 891 | 83 | 12 | GO:0007610 |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 2.37e-04 | 6 | 83 | 2 | GO:1904016 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | EOMES CACNA1A SP1 SPRY2 CXCR3 DLC1 FN1 SPTBN1 SEC23IP ENAH CEACAM6 POU2F1 GREM1 USPL1 KDM6A EP300 | 2.44e-04 | 1483 | 83 | 16 | GO:0048646 |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 2.53e-04 | 310 | 83 | 7 | GO:0005996 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | 2.77e-04 | 530 | 83 | 9 | GO:0043434 | |
| GeneOntologyBiologicalProcess | growth | TTC8 KMT2C SPRY2 MAP2K4 POC1A FN1 ARID2 CEACAM8 CEACAM6 REG1B VGLL4 GREM1 KDM6A EP300 | 3.85e-04 | 1235 | 83 | 14 | GO:0040007 |
| GeneOntologyBiologicalProcess | embryonic organ development | 4.20e-04 | 561 | 83 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | carbon catabolite activation of transcription from RNA polymerase II promoter | 4.41e-04 | 8 | 83 | 2 | GO:0000436 | |
| GeneOntologyBiologicalProcess | positive regulation of type B pancreatic cell proliferation | 4.41e-04 | 8 | 83 | 2 | GO:1904692 | |
| GeneOntologyBiologicalProcess | carbon catabolite regulation of transcription from RNA polymerase II promoter | 5.65e-04 | 9 | 83 | 2 | GO:0000429 | |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 5.65e-04 | 9 | 83 | 2 | GO:0045924 | |
| GeneOntologyBiologicalProcess | carbon catabolite activation of transcription | 5.65e-04 | 9 | 83 | 2 | GO:0045991 | |
| GeneOntologyBiologicalProcess | organ growth | 5.86e-04 | 256 | 83 | 6 | GO:0035265 | |
| Domain | Nuc_rcpt_coact | 1.68e-06 | 6 | 83 | 3 | IPR009110 | |
| Domain | DUF1518 | 5.84e-05 | 3 | 83 | 2 | PF07469 | |
| Domain | DUF1518 | 5.84e-05 | 3 | 83 | 2 | IPR010011 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 5.84e-05 | 3 | 83 | 2 | IPR014920 | |
| Domain | SRC-1 | 5.84e-05 | 3 | 83 | 2 | IPR014935 | |
| Domain | Src1_rcpt_coact | 5.84e-05 | 3 | 83 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 5.84e-05 | 3 | 83 | 2 | IPR017426 | |
| Domain | DUF1518 | 5.84e-05 | 3 | 83 | 2 | SM01151 | |
| Domain | SRC-1 | 5.84e-05 | 3 | 83 | 2 | PF08832 | |
| Domain | - | 5.84e-05 | 3 | 83 | 2 | 4.10.630.10 | |
| Domain | Nuc_rec_co-act | 5.84e-05 | 3 | 83 | 2 | PF08815 | |
| Domain | PAS | 1.81e-04 | 25 | 83 | 3 | PF00989 | |
| Domain | PAS_fold | 1.81e-04 | 25 | 83 | 3 | IPR013767 | |
| Domain | Znf_FCS | 1.93e-04 | 5 | 83 | 2 | IPR012313 | |
| Domain | ZF_FCS | 2.89e-04 | 6 | 83 | 2 | PS51024 | |
| Domain | PAS | 3.82e-04 | 32 | 83 | 3 | SM00091 | |
| Domain | VDCC_a1su_IQ | 4.04e-04 | 7 | 83 | 2 | IPR014873 | |
| Domain | GPHH | 4.04e-04 | 7 | 83 | 2 | PF16905 | |
| Domain | GPHH_dom | 4.04e-04 | 7 | 83 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 4.04e-04 | 7 | 83 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 4.04e-04 | 7 | 83 | 2 | PF08763 | |
| Domain | PAS | 4.58e-04 | 34 | 83 | 3 | IPR000014 | |
| Domain | PAS | 4.58e-04 | 34 | 83 | 3 | PS50112 | |
| Domain | SAM | 6.37e-04 | 88 | 83 | 4 | SM00454 | |
| Domain | SAM_DOMAIN | 8.49e-04 | 95 | 83 | 4 | PS50105 | |
| Domain | VDCCAlpha1 | 8.58e-04 | 10 | 83 | 2 | IPR002077 | |
| Domain | SAM | 9.18e-04 | 97 | 83 | 4 | IPR001660 | |
| Domain | - | 1.42e-03 | 109 | 83 | 4 | 4.10.280.10 | |
| Domain | Dynein_HC_stalk | 1.72e-03 | 14 | 83 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.72e-03 | 14 | 83 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.72e-03 | 14 | 83 | 2 | PF08393 | |
| Domain | MT | 1.72e-03 | 14 | 83 | 2 | PF12777 | |
| Domain | HLH | 1.78e-03 | 116 | 83 | 4 | SM00353 | |
| Domain | SAM/pointed | 1.84e-03 | 117 | 83 | 4 | IPR013761 | |
| Domain | BHLH | 1.84e-03 | 117 | 83 | 4 | PS50888 | |
| Domain | bHLH_dom | 1.89e-03 | 118 | 83 | 4 | IPR011598 | |
| Domain | DHC_fam | 1.97e-03 | 15 | 83 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.97e-03 | 15 | 83 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 1.97e-03 | 15 | 83 | 2 | PF03028 | |
| Domain | SAM_1 | 3.44e-03 | 68 | 83 | 3 | PF00536 | |
| Domain | PAC | 5.92e-03 | 26 | 83 | 2 | IPR001610 | |
| Domain | Bromodomain_CS | 5.92e-03 | 26 | 83 | 2 | IPR018359 | |
| Domain | PAC | 5.92e-03 | 26 | 83 | 2 | SM00086 | |
| Domain | TPR_REGION | 6.28e-03 | 165 | 83 | 4 | PS50293 | |
| Domain | TPR | 6.28e-03 | 165 | 83 | 4 | PS50005 | |
| Pathway | PID_AR_TF_PATHWAY | 1.22e-07 | 53 | 63 | 6 | M151 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.44e-06 | 44 | 63 | 5 | M27295 | |
| Pathway | REACTOME_FIBRONECTIN_MATRIX_FORMATION | 1.69e-06 | 6 | 63 | 3 | M26970 | |
| Pathway | PID_HES_HEY_PATHWAY | 2.24e-06 | 48 | 63 | 5 | M288 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 4.31e-06 | 149 | 63 | 7 | M27888 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 8.73e-06 | 63 | 63 | 5 | MM15613 | |
| Pathway | WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY | 1.04e-05 | 31 | 63 | 4 | M39476 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.10e-05 | 66 | 63 | 5 | M255 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 2.14e-05 | 37 | 63 | 4 | M27797 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.93e-05 | 40 | 63 | 4 | MM15000 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 3.18e-05 | 82 | 63 | 5 | M2 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 5.25e-05 | 91 | 63 | 5 | M39700 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 5.40e-05 | 220 | 63 | 7 | M27794 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 6.62e-05 | 18 | 63 | 3 | M26942 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.62e-05 | 18 | 63 | 3 | MM14775 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 1.35e-04 | 439 | 63 | 9 | M42563 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.80e-04 | 118 | 63 | 5 | M27316 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 1.82e-04 | 25 | 63 | 3 | M11184 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 2.30e-04 | 27 | 63 | 3 | MM14844 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 2.57e-04 | 28 | 63 | 3 | M48253 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 2.91e-04 | 6 | 63 | 2 | MM15660 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 2.91e-04 | 6 | 63 | 2 | MM14521 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 3.14e-04 | 133 | 63 | 5 | MM15529 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 3.17e-04 | 30 | 63 | 3 | M207 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 3.39e-04 | 296 | 63 | 7 | M27869 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 3.85e-04 | 32 | 63 | 3 | M39567 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EOMES NCOA2 FOXO1 KMT2C EEF1E1 SPTBN1 ENAH TNRC6A DNM3 NCOA1 MAML2 GREM1 ROBO3 USF1 KDM6A EP300 | 4.25e-04 | 1432 | 63 | 16 | M509 |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 4.44e-04 | 80 | 63 | 4 | M223 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 4.61e-04 | 34 | 63 | 3 | MM15531 | |
| Pathway | PID_HIF2PATHWAY | 4.61e-04 | 34 | 63 | 3 | M44 | |
| Pathway | PID_REG_GR_PATHWAY | 4.88e-04 | 82 | 63 | 4 | M115 | |
| Pathway | WP_GLIOBLASTOMA_SIGNALING | 5.11e-04 | 83 | 63 | 4 | M39637 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 5.41e-04 | 8 | 63 | 2 | M22058 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 5.93e-04 | 37 | 63 | 3 | M29790 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 6.47e-04 | 237 | 63 | 6 | M27786 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.93e-04 | 39 | 63 | 3 | MM14604 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 8.62e-04 | 42 | 63 | 3 | M17541 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 8.62e-04 | 42 | 63 | 3 | M27172 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 8.64e-04 | 10 | 63 | 2 | MM15535 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 8.64e-04 | 10 | 63 | 2 | M27945 | |
| Pathway | PID_HNF3A_PATHWAY | 9.89e-04 | 44 | 63 | 3 | M285 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 1.03e-03 | 100 | 63 | 4 | MM15826 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.05e-03 | 11 | 63 | 2 | M48021 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.05e-03 | 11 | 63 | 2 | MM14498 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 1.05e-03 | 11 | 63 | 2 | M26924 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 1.05e-03 | 11 | 63 | 2 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.05e-03 | 11 | 63 | 2 | M47958 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 1.05e-03 | 11 | 63 | 2 | M47503 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 1.06e-03 | 45 | 63 | 3 | M39615 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.20e-03 | 47 | 63 | 3 | M29777 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.20e-03 | 47 | 63 | 3 | M7946 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.26e-03 | 12 | 63 | 2 | M27159 | |
| Pathway | WP_ENERGY_METABOLISM | 1.27e-03 | 48 | 63 | 3 | M39590 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.32e-03 | 272 | 63 | 6 | M29619 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.35e-03 | 49 | 63 | 3 | M41832 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 1.35e-03 | 49 | 63 | 3 | M48250 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.49e-03 | 13 | 63 | 2 | MM15622 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 1.52e-03 | 51 | 63 | 3 | M39457 | |
| Pathway | REACTOME_SUMOYLATION | 1.54e-03 | 189 | 63 | 5 | M27214 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.61e-03 | 52 | 63 | 3 | M2404 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.61e-03 | 191 | 63 | 5 | MM15586 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | FOXO1 INTS10 SP1 PHC3 ARNT TNRC6A PPP1R13B POU2F1 MAML2 KDM6A EP300 PHC1 | 1.67e-03 | 1022 | 63 | 12 | MM15436 |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.73e-03 | 14 | 63 | 2 | M27808 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.73e-03 | 14 | 63 | 2 | M27074 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.73e-03 | 14 | 63 | 2 | MM14748 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.85e-03 | 197 | 63 | 5 | M27188 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.89e-03 | 55 | 63 | 3 | M27001 | |
| Pathway | BIOCARTA_HIF_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M13324 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 1.99e-03 | 15 | 63 | 2 | M119 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.21e-03 | 301 | 63 | 6 | MM15983 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 2.27e-03 | 16 | 63 | 2 | M27121 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS | 2.27e-03 | 16 | 63 | 2 | M27403 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 2.27e-03 | 16 | 63 | 2 | M27940 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 2.27e-03 | 16 | 63 | 2 | M46428 | |
| Pathway | PID_NOTCH_PATHWAY | 2.31e-03 | 59 | 63 | 3 | M17 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 2.34e-03 | 125 | 63 | 4 | M27186 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.55e-03 | 61 | 63 | 3 | M39540 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 2.72e-03 | 314 | 63 | 6 | M39428 | |
| Pathway | WP_ADIPOGENESIS | 2.78e-03 | 131 | 63 | 4 | M39505 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 2.87e-03 | 18 | 63 | 2 | M4862 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.87e-03 | 18 | 63 | 2 | MM15034 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 2.92e-03 | 64 | 63 | 3 | M200 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 2.92e-03 | 64 | 63 | 3 | M5650 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.05e-03 | 65 | 63 | 3 | M39682 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 3.19e-03 | 66 | 63 | 3 | MM14839 | |
| Pathway | REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS | 3.20e-03 | 19 | 63 | 2 | MM14612 | |
| Pathway | WP_ADIPOGENESIS_GENES | 3.26e-03 | 137 | 63 | 4 | MM15970 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 3.55e-03 | 20 | 63 | 2 | M27881 | |
| Pathway | PID_CDC42_PATHWAY | 3.76e-03 | 70 | 63 | 3 | M81 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 3.76e-03 | 70 | 63 | 3 | M938 | |
| Pathway | WP_AXON_GUIDANCE | 4.07e-03 | 72 | 63 | 3 | M48335 | |
| Pubmed | 6.16e-09 | 233 | 85 | 9 | 37704626 | ||
| Pubmed | 5.63e-08 | 4 | 85 | 3 | 12024042 | ||
| Pubmed | A simple method to screen ligands of peroxisome proliferator-activated receptor delta. | 5.63e-08 | 4 | 85 | 3 | 16930961 | |
| Pubmed | 1.40e-07 | 5 | 85 | 3 | 12714702 | ||
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 1.40e-07 | 5 | 85 | 3 | 9812974 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.06e-07 | 351 | 85 | 9 | 38297188 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 16923966 | ||
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 2.80e-07 | 6 | 85 | 3 | 15615775 | |
| Pubmed | 2.80e-07 | 6 | 85 | 3 | 10973497 | ||
| Pubmed | 2.93e-07 | 57 | 85 | 5 | 18022353 | ||
| Pubmed | SP1 KMT2C IFT140 ARID2 SPTBN1 TNRC6A ADNP2 PPP1R13B CHD8 EP300 | 3.18e-07 | 486 | 85 | 10 | 20936779 | |
| Pubmed | NCOA2 SP1 MXRA5 ARID2 SEC23IP DNAH2 NCOA1 BSN CSPP1 KDM6A EP300 | 4.54e-07 | 638 | 85 | 11 | 31182584 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 4.90e-07 | 7 | 85 | 3 | 9590696 | |
| Pubmed | 4.90e-07 | 7 | 85 | 3 | 12709428 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.88e-07 | 398 | 85 | 9 | 35016035 | |
| Pubmed | 7.82e-07 | 8 | 85 | 3 | 12082103 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.20e-06 | 220 | 85 | 7 | 35785414 | |
| Pubmed | Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. | 1.67e-06 | 10 | 85 | 3 | 22421440 | |
| Pubmed | NCOA2 SP1 KMT2C PHC3 ARNT ARID2 SPTBN1 TNRC6A PPP1R13B NCOA1 POU2F1 CHD8 VGLL4 KDM6A EP300 | 1.79e-06 | 1429 | 85 | 15 | 35140242 | |
| Pubmed | 2.51e-06 | 157 | 85 | 6 | 30186101 | ||
| Pubmed | NCOA2 SPRY2 UBA7 UBQLN2 CELSR3 FN1 POLG SPTBN1 SEC23IP ADNP2 DNM3 USPL1 KDM6A EP300 | 2.70e-06 | 1285 | 85 | 14 | 35914814 | |
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 4.10e-06 | 265 | 85 | 7 | 19240061 | |
| Pubmed | NCOA2 FOXO1 SP1 ARNT ARID2 NCOA1 POU2F1 USF1 ZNF236 KDM6A PHC1 | 4.45e-06 | 808 | 85 | 11 | 20412781 | |
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 5.03e-06 | 14 | 85 | 3 | 11500849 | |
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 12482968 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8668525 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 36527113 | ||
| Pubmed | SRC-1 and TIF2 control energy balance between white and brown adipose tissues. | 5.90e-06 | 2 | 85 | 2 | 12507421 | |
| Pubmed | Downregulation of decidual SP1 and P300 is associated with severe preeclampsia. | 5.90e-06 | 2 | 85 | 2 | 29273682 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 21470677 | ||
| Pubmed | Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction. | 5.90e-06 | 2 | 85 | 2 | 15070739 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11897715 | ||
| Pubmed | Distinct steady-state nuclear receptor coregulator complexes exist in vivo. | 5.90e-06 | 2 | 85 | 2 | 9751728 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 8776764 | ||
| Pubmed | Acetylation curtails nucleosome binding, not stable nucleosome remodeling, by FoxO1. | 5.90e-06 | 2 | 85 | 2 | 19146829 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 25148457 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 31222613 | ||
| Pubmed | High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias. | 5.90e-06 | 2 | 85 | 2 | 17909799 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11095950 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 19116449 | ||
| Pubmed | O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. | 5.90e-06 | 2 | 85 | 2 | 19070619 | |
| Pubmed | The Kelch-like protein 1 modulates P/Q-type calcium current density. | 5.90e-06 | 2 | 85 | 2 | 17289272 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16381801 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 2022629 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 34252870 | ||
| Pubmed | P300 plays a role in p16(INK4a) expression and cell cycle arrest. | 5.90e-06 | 2 | 85 | 2 | 17906698 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16410262 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 11590190 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 10651903 | ||
| Pubmed | CRE promoter sites modulate alternative splicing via p300-mediated histone acetylation. | 5.90e-06 | 2 | 85 | 2 | 25019513 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 23643164 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15231721 | ||
| Pubmed | 8.10e-06 | 549 | 85 | 9 | 38280479 | ||
| Pubmed | 9.35e-06 | 17 | 85 | 3 | 19183483 | ||
| Pubmed | 1.56e-05 | 20 | 85 | 3 | 11877444 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9525610 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 16914740 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15890677 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 31478331 | ||
| Pubmed | Absence of the steroid receptor coactivator-3 induces B-cell lymphoma. | 1.77e-05 | 3 | 85 | 2 | 16675958 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 37410700 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 17045797 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 22415975 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 38996073 | ||
| Pubmed | Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a. | 1.77e-05 | 3 | 85 | 2 | 11773079 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 33574497 | ||
| Pubmed | The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. | 1.77e-05 | 3 | 85 | 2 | 12138202 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 17167768 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 11030335 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 18588874 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 32187044 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12114525 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 31536933 | ||
| Pubmed | Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival. | 1.77e-05 | 3 | 85 | 2 | 17599098 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15983373 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 14514691 | ||
| Pubmed | Expression of tenascin in developing and adult mouse lymphoid organs. | 1.77e-05 | 3 | 85 | 2 | 7687262 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19953635 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20603618 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 21035760 | ||
| Pubmed | Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors. | 1.77e-05 | 3 | 85 | 2 | 24550004 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 21059860 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 22033265 | ||
| Pubmed | RORgammat recruits steroid receptor coactivators to ensure thymocyte survival. | 1.77e-05 | 3 | 85 | 2 | 16148126 | |
| Pubmed | The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. | 1.77e-05 | 3 | 85 | 2 | 8855229 | |
| Pubmed | T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. | 1.77e-05 | 3 | 85 | 2 | 20713880 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10471301 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 20508969 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9506940 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 28390937 | ||
| Pubmed | p300 functions as a coactivator for the peroxisome proliferator-activated receptor alpha. | 1.77e-05 | 3 | 85 | 2 | 9407140 | |
| Pubmed | The role of SRC1 and SRC2 in steroid-induced SDF1 expression in normal and ectopic endometrium. | 1.77e-05 | 3 | 85 | 2 | 24586072 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 12482985 | ||
| Pubmed | Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences. | 1.77e-05 | 3 | 85 | 2 | 23927929 | |
| Pubmed | Co-activator SRC-1 is dispensable for transcriptional control by STAT3. | 1.77e-05 | 3 | 85 | 2 | 19203349 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 18845648 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 14757047 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.77e-05 | 3 | 85 | 2 | 24523520 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10999956 | ||
| Pubmed | Structure and chromosomal locations of mouse steroid receptor coactivator gene family. | 1.77e-05 | 3 | 85 | 2 | 10501088 | |
| Interaction | SOX7 interactions | 5.44e-08 | 82 | 85 | 7 | int:SOX7 | |
| Interaction | BAG2 interactions | NCOA2 FOXO1 SP1 PHC3 ARNT FN1 POLG ENAH DNAH2 PPP1R13B POU2F1 KDM6A EP300 PHC1 | 3.10e-07 | 622 | 85 | 14 | int:BAG2 |
| Interaction | CRX interactions | 1.25e-06 | 254 | 85 | 9 | int:CRX | |
| Interaction | PGR interactions | 1.47e-06 | 84 | 85 | 6 | int:PGR | |
| Interaction | FEV interactions | 2.29e-06 | 203 | 85 | 8 | int:FEV | |
| Interaction | HNF4A interactions | 2.40e-06 | 275 | 85 | 9 | int:HNF4A | |
| Interaction | MEF2C interactions | 3.19e-06 | 54 | 85 | 5 | int:MEF2C | |
| Interaction | SOX9 interactions | 3.42e-06 | 97 | 85 | 6 | int:SOX9 | |
| Interaction | EGR2 interactions | 7.92e-06 | 171 | 85 | 7 | int:EGR2 | |
| Interaction | VEGFA interactions | 8.65e-06 | 66 | 85 | 5 | int:VEGFA | |
| Interaction | TEAD1 interactions | 9.57e-06 | 176 | 85 | 7 | int:TEAD1 | |
| Interaction | CEACAM6 interactions | 1.24e-05 | 34 | 85 | 4 | int:CEACAM6 | |
| Interaction | RORA interactions | 2.17e-05 | 39 | 85 | 4 | int:RORA | |
| Interaction | HNF1A interactions | 2.22e-05 | 80 | 85 | 5 | int:HNF1A | |
| Interaction | SRF interactions | 2.70e-05 | 139 | 85 | 6 | int:SRF | |
| Interaction | TLX3 interactions | 3.16e-05 | 291 | 85 | 8 | int:TLX3 | |
| Interaction | GSC interactions | 3.34e-05 | 87 | 85 | 5 | int:GSC | |
| Interaction | NCOA6 interactions | 3.43e-05 | 145 | 85 | 6 | int:NCOA6 | |
| Interaction | ELF5 interactions | 3.70e-05 | 147 | 85 | 6 | int:ELF5 | |
| Interaction | SP7 interactions | 4.30e-05 | 304 | 85 | 8 | int:SP7 | |
| Interaction | SOX10 interactions | 4.37e-05 | 92 | 85 | 5 | int:SOX10 | |
| Interaction | RARA interactions | 4.39e-05 | 223 | 85 | 7 | int:RARA | |
| Interaction | PPARG interactions | 4.61e-05 | 307 | 85 | 8 | int:PPARG | |
| Interaction | SOX17 interactions | 5.10e-05 | 95 | 85 | 5 | int:SOX17 | |
| Interaction | FOS interactions | 5.16e-05 | 312 | 85 | 8 | int:FOS | |
| Interaction | WWTR1 interactions | 7.18e-05 | 422 | 85 | 9 | int:WWTR1 | |
| Interaction | ARNT interactions | 1.02e-04 | 255 | 85 | 7 | int:ARNT | |
| Interaction | NR2F1 interactions | 1.05e-04 | 58 | 85 | 4 | int:NR2F1 | |
| Interaction | ASH2L interactions | 1.29e-04 | 265 | 85 | 7 | int:ASH2L | |
| Interaction | THRB interactions | 1.36e-04 | 186 | 85 | 6 | int:THRB | |
| Interaction | NR6A1 interactions | 1.37e-04 | 24 | 85 | 3 | int:NR6A1 | |
| Interaction | ETS1 interactions | 1.61e-04 | 121 | 85 | 5 | int:ETS1 | |
| Interaction | MYOD1 interactions | 1.71e-04 | 194 | 85 | 6 | int:MYOD1 | |
| Interaction | PAX7 interactions | 1.80e-04 | 124 | 85 | 5 | int:PAX7 | |
| Interaction | TLE3 interactions | 1.88e-04 | 376 | 85 | 8 | int:TLE3 | |
| Interaction | VDR interactions | 2.01e-04 | 127 | 85 | 5 | int:VDR | |
| Interaction | AHR interactions | 2.41e-04 | 132 | 85 | 5 | int:AHR | |
| Interaction | SOX15 interactions | 3.27e-04 | 141 | 85 | 5 | int:SOX15 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.40e-05 | 17 | 61 | 3 | 486 | |
| GeneFamily | Basic helix-loop-helix proteins | 5.18e-04 | 110 | 61 | 4 | 420 | |
| GeneFamily | CD molecules|V-set domain containing|Immunoglobulin like domain containing|Carcinoembryonic antigen related cell adhesion molecule family | 2.95e-03 | 24 | 61 | 2 | 906 | |
| GeneFamily | Sterile alpha motif domain containing | 3.27e-03 | 88 | 61 | 3 | 760 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.45e-03 | 26 | 61 | 2 | 253 | |
| GeneFamily | Immunoglobulin like domain containing | 4.09e-03 | 193 | 61 | 4 | 594 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th.TCRbko, TCRd+ Vg2- CD24+, Thymus, avg-3 | 1.64e-05 | 80 | 84 | 5 | GSM605799_100 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.49e-07 | 168 | 85 | 6 | 8c8dbdbc7053f34e4ca0c5067af502fbea109fc1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-06 | 199 | 85 | 6 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 155 | 85 | 5 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 155 | 85 | 5 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 167 | 85 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 173 | 85 | 5 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | RV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.26e-05 | 177 | 85 | 5 | f0edf04930692418953e4f00a917257804ec0ffd | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 2.59e-05 | 182 | 85 | 5 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.73e-05 | 184 | 85 | 5 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 185 | 85 | 5 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.87e-05 | 186 | 85 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.02e-05 | 188 | 85 | 5 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 3.10e-05 | 189 | 85 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-05 | 191 | 85 | 5 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.42e-05 | 193 | 85 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-05 | 193 | 85 | 5 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-05 | 193 | 85 | 5 | 1f978e102a029a6beb10913052cd0a20c7253e8e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.51e-05 | 194 | 85 | 5 | ad6c04ad0621689e3bf4c94ccd6e60653bbd02c7 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 3.51e-05 | 194 | 85 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 196 | 85 | 5 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 196 | 85 | 5 | 8f2031b1a9232c389517fbf3c29f47f9468b0077 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 196 | 85 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 196 | 85 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 196 | 85 | 5 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.69e-05 | 196 | 85 | 5 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-05 | 196 | 85 | 5 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 197 | 85 | 5 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 197 | 85 | 5 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.78e-05 | 197 | 85 | 5 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 200 | 85 | 5 | b1be27d134a8633e3e7862c6a0d7be2001d387f0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 200 | 85 | 5 | dba96cda5f3b780a3d4171b61bc8aaddc1f5d466 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 200 | 85 | 5 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-05 | 200 | 85 | 5 | 7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.08e-05 | 123 | 85 | 4 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-04 | 127 | 85 | 4 | eee8e4a83f7de46807440d202d46eee7dd722001 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Nonmucinous_Lepidic_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.12e-04 | 130 | 85 | 4 | 17a4ee699adfa265335b1abfe6cb0f3f7c93362b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 142 | 85 | 4 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.58e-04 | 142 | 85 | 4 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | IIF-Lymphocyte-T_NK-dnT|IIF / Disease, Lineage and Cell Type | 1.76e-04 | 146 | 85 | 4 | d0f361662db5f7be26104346e8431f7e30c5ce3a | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.80e-04 | 147 | 85 | 4 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 154 | 85 | 4 | bd283c2367afb99294e7576a0c0167eb7c69ad6b | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 155 | 85 | 4 | 93513bab53b40e9c3c91ab8e3316ea00a4f66cd2 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 158 | 85 | 4 | 9f0987eaf1766aadb5714b68df7a5d310ea5a57a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.43e-04 | 159 | 85 | 4 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.43e-04 | 159 | 85 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | droplet-Liver-LIVER_NPC-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 159 | 85 | 4 | 997963d879e5819683793cddf5e1acff1b81a1b8 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 159 | 85 | 4 | 94bc6ab248a8f02ccbc0facd24e0c7e9fda687d2 | |
| ToppCell | droplet-Liver-LIVER_NPC|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 159 | 85 | 4 | e4eaa88772835d6b78e1a18a0cec52de51e80339 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.55e-04 | 161 | 85 | 4 | 0605134a342d74ae81f33700d6ddfcd6e03aeb7b | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroid_progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 162 | 85 | 4 | d0ffebf5adee8a3ac9b81a4b793184f54010489a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 162 | 85 | 4 | 9b1c07f0af657095379380c39d763cab0ad73e74 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-04 | 162 | 85 | 4 | 5428c9fdb816f564395ebb4520448e5f3a42b025 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-04 | 163 | 85 | 4 | 63b0badaee3b2d827b1f4524510e3384d8f8fcde | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 164 | 85 | 4 | 9fed5df40f50bde35db8bf89c291cbdc0e104112 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 164 | 85 | 4 | e712d6b89461f741dbd773ba9a27ecaddf97cbaa | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-04 | 164 | 85 | 4 | ab9c17f86b98e1a4d5db1bd3086edab1320ebda8 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.80e-04 | 165 | 85 | 4 | 7d319a112b9062efee428bef6f4534d2ce782e04 | |
| ToppCell | LV-11._Adipocyte|World / Chamber and Cluster_Paper | 2.87e-04 | 166 | 85 | 4 | 7e5852891714465c6228c9f955fd511ec79d0e02 | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.93e-04 | 167 | 85 | 4 | 895844a45721988788d01120eb880603ba3ca139 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.93e-04 | 167 | 85 | 4 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 168 | 85 | 4 | e156297a7515e785a9e79a9676700bd3a9d92b98 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-04 | 168 | 85 | 4 | 32e0bc0873baa13027241063283ef26d2aab56f5 | |
| ToppCell | Immune_cells-NK_cells|Immune_cells / Lineage and Cell class | 3.00e-04 | 168 | 85 | 4 | 125d70c37eb49eb4d1f503bb8d536b225254c7cb | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|World / disease group, cell group and cell class (v2) | 3.07e-04 | 169 | 85 | 4 | 2bda6ab3f32e05cb7daf91eb7c39b4fcc9ae91bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.07e-04 | 169 | 85 | 4 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 170 | 85 | 4 | bcbe5c44ef708c5f01dc7dd9aec7b436e1a62d56 | |
| ToppCell | control-dn_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.14e-04 | 170 | 85 | 4 | 839f62860b4a52d06e6a8fce7632195c7310b89d | |
| ToppCell | 368C-Lymphocytic-ILC|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 171 | 85 | 4 | 3b3143e4aa6520ee9c6b6f2482206ad3d8205d14 | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-04 | 171 | 85 | 4 | fd01076574dcc82bfd4a1538812500543b16794f | |
| ToppCell | mild_COVID-19_(asymptomatic)-RBC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.21e-04 | 171 | 85 | 4 | 78491478ba65bad45238fe114f5251b2adea323d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.21e-04 | 171 | 85 | 4 | 317b70d72a4ca5336cfb6a49dc57f8e2a8a1c736 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.28e-04 | 172 | 85 | 4 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 173 | 85 | 4 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | facs-Marrow-T-cells|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | 806f94f5c3ac836ddffc389d3c2cd7e4da7a608d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-04 | 173 | 85 | 4 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | LV-11._Adipocyte|LV / Chamber and Cluster_Paper | 3.35e-04 | 173 | 85 | 4 | c2d3fcb3de71015d03d14c63450853d2b03ffa71 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.43e-04 | 174 | 85 | 4 | 4a18b51501eaaeb7907e99316ba8ae15b2c7d529 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 177 | 85 | 4 | 650095a17e1a39caea74a6e89646565b9332af5d | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 177 | 85 | 4 | d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb | |
| ToppCell | RV-11._Adipocyte|RV / Chamber and Cluster_Paper | 3.74e-04 | 178 | 85 | 4 | 278bbea5cf8f0589f71675c7a3d00679391b5253 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.74e-04 | 178 | 85 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.82e-04 | 179 | 85 | 4 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-04 | 179 | 85 | 4 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.90e-04 | 180 | 85 | 4 | 62511d76d24b836839c3dcc2bf30485ffe9401e2 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.90e-04 | 180 | 85 | 4 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.90e-04 | 180 | 85 | 4 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-04 | 180 | 85 | 4 | ff34195bb7325e61fbf823c103c5e6115d8f1248 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.98e-04 | 181 | 85 | 4 | 986c036e656f24fe374807e2711cec9e3c83c892 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-04 | 181 | 85 | 4 | a2c03bd7adc4a65f3b373c229ec0ecc84f724b17 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 3.98e-04 | 181 | 85 | 4 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 3.98e-04 | 181 | 85 | 4 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-mature_NK_T_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-04 | 181 | 85 | 4 | c073e6c917354528ac5bad88a226e1134004ba43 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 4.06e-04 | 182 | 85 | 4 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 182 | 85 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 182 | 85 | 4 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-04 | 182 | 85 | 4 | 03992d0ae519795239e4f2cc8e63f33c4482de6a | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 182 | 85 | 4 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 182 | 85 | 4 | 35b2a5625323bf0917214d3b82fafc4a8f5e75ff | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|kidney / Disease (COVID-19 only), tissue and cell type | 4.15e-04 | 183 | 85 | 4 | 3c4153479fc4ab2d073d92cee120480015555914 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Macroglial-Schwann_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 183 | 85 | 4 | 2cf36ad89584eb9f8b04de52a1b511b7f3527884 | |
| Drug | Doxylamine succinate [562-10-7]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 8.01e-07 | 199 | 85 | 8 | 1473_UP | |
| Drug | diallyl | 2.16e-06 | 25 | 85 | 4 | CID000011598 | |
| Drug | NASN | 5.91e-06 | 10 | 85 | 3 | CID000000184 | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 8.52e-06 | 195 | 85 | 7 | 3942_DN | |
| Drug | Colchicine [64-86-8]; Down 200; 10uM; PC3; HT_HG-U133A | 8.52e-06 | 195 | 85 | 7 | 4614_DN | |
| Disease | prostate cancer (is_marker_for) | 5.35e-06 | 156 | 83 | 6 | DOID:10283 (is_marker_for) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 2.34e-05 | 3 | 83 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | colorectal cancer (is_implicated_in) | 2.40e-05 | 121 | 83 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | migraine (implicated_via_orthology) | 4.67e-05 | 4 | 83 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | risk-taking behaviour | CACNA1E SPRY2 MDFIC PSORS1C1 ATAD2B TNRC6A PPP1R13B USPL1 TNXB EP300 | 5.65e-05 | 764 | 83 | 10 | EFO_0008579 |
| Disease | adenoid cystic carcinoma (is_implicated_in) | 7.77e-05 | 5 | 83 | 2 | DOID:0080202 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of esophagus | 1.52e-04 | 95 | 83 | 4 | C0279626 | |
| Disease | tumor necrosis factor ligand superfamily member 6, soluble form measurement | 1.63e-04 | 7 | 83 | 2 | EFO_0020797 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.63e-04 | 7 | 83 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | hepatocyte growth factor-like protein measurement | 1.69e-04 | 38 | 83 | 3 | EFO_0008154 | |
| Disease | non-high density lipoprotein cholesterol measurement | 1.78e-04 | 713 | 83 | 9 | EFO_0005689 | |
| Disease | alcohol consumption measurement | NCOA2 CACNA1A CACNA1E SYN3 ARID2 SPTBN1 TNRC6A DNAH2 PPP1R13B MYO15A EP300 CA5A | 1.80e-04 | 1242 | 83 | 12 | EFO_0007878 |
| Disease | Carcinoma, Transitional Cell | 2.12e-04 | 41 | 83 | 3 | C0007138 | |
| Disease | uterine fibroid | 2.51e-04 | 199 | 83 | 5 | EFO_0000731 | |
| Disease | renovascular hypertension (implicated_via_orthology) | 2.78e-04 | 9 | 83 | 2 | DOID:1591 (implicated_via_orthology) | |
| Disease | Macrocephaly | 4.23e-04 | 11 | 83 | 2 | C0221355 | |
| Disease | Benign tumor of pancreas | 5.98e-04 | 13 | 83 | 2 | C0347284 | |
| Disease | FEV/FEC ratio | FOXO1 SPRY2 MAP2K4 DLC1 SYN3 EEF1E1 THG1L VGLL4 MAML2 MYO15A TNXB | 6.43e-04 | 1228 | 83 | 11 | EFO_0004713 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 6.50e-04 | 139 | 83 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 6.67e-04 | 140 | 83 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 6.85e-04 | 141 | 83 | 4 | C0005684 | |
| Disease | malignant pleural mesothelioma (is_marker_for) | 6.96e-04 | 14 | 83 | 2 | DOID:7474 (is_marker_for) | |
| Disease | red blood cell density measurement | 8.20e-04 | 880 | 83 | 9 | EFO_0007978 | |
| Disease | endoplasmic reticulum resident protein 29 measurement | 9.14e-04 | 16 | 83 | 2 | EFO_0020346 | |
| Disease | sex interaction measurement, ulcerative colitis | 1.03e-03 | 17 | 83 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | Pancreatic carcinoma | 1.30e-03 | 19 | 83 | 2 | C0235974 | |
| Disease | glomerulonephritis (is_marker_for) | 1.30e-03 | 19 | 83 | 2 | DOID:2921 (is_marker_for) | |
| Disease | anthropometric measurement | 1.31e-03 | 168 | 83 | 4 | EFO_0004302 | |
| Disease | Inguinal hernia | 1.32e-03 | 287 | 83 | 5 | HP_0000023 | |
| Disease | cortical surface area measurement | NCOA2 CACNA1A SP1 SPRY2 ATAD2B SPTBN1 TNRC6A GAL3ST4 MIR1915HG TNXB KIAA1614 | 1.35e-03 | 1345 | 83 | 11 | EFO_0010736 |
| Disease | Leukemia, Myelocytic, Acute | 1.46e-03 | 173 | 83 | 4 | C0023467 | |
| Disease | progranulin measurement | 1.74e-03 | 22 | 83 | 2 | EFO_0004625 | |
| Disease | Primary microcephaly | 1.74e-03 | 22 | 83 | 2 | C0431350 | |
| Disease | Uterine leiomyoma | 2.18e-03 | 91 | 83 | 3 | HP_0000131 | |
| Disease | systemic mastocytosis | 2.25e-03 | 25 | 83 | 2 | MONDO_0016586 | |
| Disease | Left Ventricular Hypertrophy | 2.25e-03 | 25 | 83 | 2 | C0149721 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.26e-03 | 195 | 83 | 4 | DOID:1574 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of large intestine | 2.54e-03 | 96 | 83 | 3 | C1319315 | |
| Disease | ulcerative colitis | 2.58e-03 | 335 | 83 | 5 | EFO_0000729 | |
| Disease | Colorectal cancer | 2.62e-03 | 27 | 83 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 2.62e-03 | 27 | 83 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 2.62e-03 | 27 | 83 | 2 | cv:C0009404 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IINPGNPTGQVQSRK | 266 | Q8TD30 | |
| GPNLSTTRPIQQDLG | 1041 | O00555 | |
| SNTIQRPQLGPTANL | 476 | P27540 | |
| LGCPNQRGLQRQPSS | 336 | P49682 | |
| NGERTVPQTNGLLSP | 491 | O95936 | |
| GQQIPNSLSNQVRSP | 2296 | Q09472 | |
| RITLVLQQPQSGGPQ | 286 | Q9HCK8 | |
| QSRNRQGTPVPASGQ | 21 | Q15878 | |
| NGQSLPVSPRLQLSN | 181 | P31997 | |
| AGQTVQLTGQPNITP | 956 | Q68CP9 | |
| LQPQSSGVQGQVPIS | 96 | Q9H467 | |
| LQPGTSPAQTGQLQS | 691 | Q17RM4 | |
| LSRGIQGQTQASPQP | 2426 | Q96M86 | |
| QPGSSQQIQQRISVP | 511 | Q96KQ4 | |
| LPVNQPVRPGASQNT | 576 | Q6IQ32 | |
| TARFTLNPNPTGVQN | 56 | P45985 | |
| SSNGQLPSRPQSAQI | 1641 | Q9H0J4 | |
| QGSISQPQITGQGTL | 476 | Q9NVR2 | |
| SSRPQHPGQQQQRTP | 106 | Q8WTU0 | |
| PGRGRSVESVQSQPQ | 336 | Q8NBT0 | |
| TTGQQRPLQVPGASA | 46 | Q5T4H9 | |
| LGQSQPTVAGQPSAR | 451 | Q16849 | |
| PPQQIQGSGVSPQLR | 2501 | Q8NEZ4 | |
| QNRSFPLPGVQSSGQ | 6 | Q7Z3D4 | |
| QRLPQLQTSAQVPSG | 76 | Q9P1T7 | |
| QTQSPQQPGSRNRGR | 46 | O60565 | |
| QQQGSGAARTLPPTQ | 2196 | Q9UKN7 | |
| QARLTSQPGATLPNG | 121 | Q9ULI0 | |
| NGQSLPVSPRLQLSN | 181 | P40199 | |
| TNPNNPVTVIRGLAG | 961 | O15550 | |
| SLQDSGQNRTVGPNP | 346 | Q5VZ46 | |
| QIPSGAASRQPQTQQ | 3766 | Q9UPA5 | |
| TVGNQGTNLPPSRQI | 511 | Q9UQ16 | |
| RSQASGNQPPSILGQ | 476 | Q9HCD5 | |
| IPPNSQQTRGSLGID | 91 | Q1MSJ5 | |
| PQQPQVLSSEGGQLR | 56 | P54098 | |
| QVLPSGAGPRAQTLN | 241 | Q96RP7 | |
| IGPVQQSALVSPGQQ | 466 | Q8NDX5 | |
| QNNLNRPGPQRTTSV | 291 | Q86Y01 | |
| QTPPLAQQRLGSGSF | 431 | Q9NZB8 | |
| GGQITGLTLTPAQQQ | 106 | P14859 | |
| VIENRQPPSSNGLSQ | 286 | Q9NPB6 | |
| GTGLNQSRTGINQPP | 1066 | Q8IZL2 | |
| LQTQRGLPGSSPQQE | 256 | Q2TBC4 | |
| VSVPGGTRQSPINIQ | 56 | P35218 | |
| DPGVAQPNSRVLGQN | 481 | Q12778 | |
| GRPAVNSPANQSRGN | 356 | Q6ZUS6 | |
| QLPGTSGQQPSVGQQ | 2126 | P02751 | |
| ERQLQSTGPEQNPGT | 231 | Q8ND71 | |
| LQGPGLTTTESRQQP | 826 | P10253 | |
| LNSQETGPTLPRQNS | 111 | Q8N8S7 | |
| GRPPLSNNTGLASIQ | 626 | Q9NYQ7 | |
| LQPQITPTRAGGQTR | 4136 | Q9P225 | |
| VQETPRSQPQSANGQ | 666 | Q96RY7 | |
| RSQPQSANGQPQDGR | 671 | Q96RY7 | |
| GRGQQQLPQFLSSPS | 1391 | Q9C0B2 | |
| PNQEVPVAPSQSRQG | 536 | Q659C4 | |
| QGQESQTELPNPRIS | 21 | P48304 | |
| GERQIPVLQTNNGPS | 26 | O43324 | |
| SGNSRPPRNLQGLLQ | 36 | Q9NZL4 | |
| PSQQRLSPQGQQPLS | 456 | O14994 | |
| RQQSFGNNLPPSSGL | 1136 | Q15788 | |
| SVQSPAQQQVPARPG | 236 | Q9Y6Y8 | |
| SQGQTPQRVSGLQGS | 351 | P08047 | |
| TVNVQRTGQPLPQSI | 1081 | Q96QB1 | |
| QSGNGSQPLLQTPRD | 6 | O43597 | |
| QVSQNGLPAEQGSPR | 2126 | Q01082 | |
| SQSTFNNPRPGQLGR | 866 | Q15596 | |
| RPSSQPGQRQTLQSQ | 991 | Q15596 | |
| AGLSPTLTPGERQQN | 146 | Q14135 | |
| SNLPDSSGQQNPIRT | 151 | Q5W0Q7 | |
| QTGGPSQAVRPITQA | 101 | Q8TAM2 | |
| VSQSLQTNRGPQPGR | 136 | Q86VN1 | |
| QQLTGQAPAPGQRVL | 976 | P41226 | |
| QSGLTPVQAQGRLQG | 196 | Q9NWX6 | |
| QPTGRFSVSPRGQLN | 396 | Q96MS0 | |
| QQSTVLRGLPPGTQI | 726 | Q96MS0 | |
| STTQGAQAPLLQQRP | 946 | P22105 | |
| QRALGTQTPALQGPQ | 11 | Q9UIG5 | |
| PVQVVGTRQPGTAQA | 526 | P78364 | |
| ESGQSPQPGQQLSIT | 371 | Q9UL36 | |
| VIKSQNRPQGQSTQP | 101 | Q9UHD9 | |
| RTQNTAASQPRQPGG | 161 | Q96M66 | |
| SVPSGNRPQQDQQGR | 1431 | Q8NDV7 | |
| QASGQALPSQARNPG | 261 | Q8IZ20 | |
| PQEVLQGGSQRSIAP | 166 | P22415 | |
| QSLLGTQLPPQGRTT | 126 | P40225 | |
| TRLQQGAPGQGTQQP | 101 | Q9NR64 | |
| NPSRTAQPGRLQTGI | 1381 | Q9NR99 |